Fiber Global Raises $20 Million Series A to Scale Circular Building Materials Platform
Fiber Global, a pioneer in sustainable building materials, today announced it has raised $20 million in Series A funding. The round was led by DBL Partners, with Founder and Managing Partner Ira Ehrenpreis joining the Board of Directors. The capital will support Fiber Global’s mission to transform abundant global waste streams into scalable, sustainable building materials, starting with expansion of its U.S. manufacturing footprint.
Fiber Global’s proprietary technology platform converts abundant global waste streams into durable, high-performing building materials capable of outperforming existing solutions with a dramatically lower carbon footprint. Manufactured in the United States, Fiber Global’s products are also formaldehyde free, have zero harmful volatile organic compounds (VOCs), and are UL GREENGUARD GOLD certified. With construction materials responsible for over 10% of global greenhouse gas emissions, Fiber Global aims to lead the transition toward a climate-positive, affordable, and resilient building materials industry through a circular manufacturing approach that also strengthens local economies.
“From day one, our relationship with DBL Partners and Ira Ehrenpreis has been invaluable,”said KC McCreery, Founder and CEO of Fiber Global. “Their team brings more than just investment; they actively engage and support our growth on a daily basis with intentionality. DBL Partners and Ira Ehrenpreis are truly part of the Fiber Global team, sharing our mission and vision of reclaiming tomorrow. This investment round provides us with the ability to continue rapidly scaling our United States manufacturing footprint and production capacity."
Over the past two and a half years, Fiber Global has focused intensely on the execution and scalability of reclaiming global waste streams to build more affordable, better performing, and truly sustainable products. The company is already partnering with leading materials companies to deploy its products across multiple building materials applications, offering a low-carbon alternative without compromising on performance or cost. DBL Partners has a long-standing track record of supporting transformative companies that rethink industry norms and apply deep innovation across both product and processes to redefine what is possible at scale.
“Fiber Global exemplifies the mission-driven, execution-oriented companies DBL seeks to back,” said Ira Ehrenpreis. “KC and his team are building a platform with the potential to revolutionize the building materials sector, combining sustainability, performance, and affordability at scale. Fiber Global is building a better and more economically compelling product that also has a superior environmental footprint, demonstrating how double bottom line is not about tradeoff or compromise but about winning with the best value proposition.”
With increasing global focus on the need to decarbonize the built environment and diversify the supply chains of key building materials, Fiber Global is positioned to meet a surge in demand from partners seeking high-performance, cost-effective, and environmentally cleaner alternatives. The Series A round validates the company’s commercial traction and technology and sets the stage for broader expansion in the years ahead.
About Fiber Global
Fiber Global is a climate technology company redefining building materials through circular innovation. With a mission to reclaim abundant global waste streams to create sustainable, high performing building materials, Fiber Global is driving the shift toward a more resourceful and resilient future. Founded in 2023, the company is headquartered in Brownsburg, IN. Learn more at www.fiberglobal.com.
About DBL Partners
DBL Partners is a pioneering impact investor and among the largest in the venture asset class. The firm invests in companies that can deliver both top-tier venture capital returns and enable social, environmental, and economic benefits. DBL Partners manages over $1.5B in assets, and has helped to scale industry-transforming companies across multiple sectors, including electric vehicles, the earth-space nexus, renewable energy, circular economy, and many others. More information can be found at: www.dbl.vc.
This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding Fiber Global’s growth plans, market opportunities, product capabilities, and expected impacts. These statements are based on current assumptions and estimates and are subject to risks and uncertainties that could cause actual results to differ materially. Forward-looking statements speak only as of the date of this release, and Fiber Global undertakes no obligation to update them in light of new information or future events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250617520583/en/
Contacts
publicrelations@fiberglobal.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom